行情

ATHX

ATHX

Athersys
NASDAQ

实时行情|Nasdaq Last Sale

1.330
+0.030
+2.31%
盘后: 1.330 0 0.00% 16:00 12/06 EST
开盘
1.300
昨收
1.300
最高
1.330
最低
1.300
成交量
41.91万
成交额
--
52周最高
2.150
52周最低
1.200
市值
2.08亿
市盈率(TTM)
-4.2724
分时
5日
1月
3月
1年
5年

分析师评级

1位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

ATHX 新闻

  • Athersys slides alongside reaction to stock purchase deal
  • Seeking Alpha - Article.11/26 22:54
  • Edited Transcript of ATHX earnings conference call or presentation 6-Nov-19 9:30pm GMT
  • Thomson Reuters StreetEvents.11/25 23:56
  • Athersys, Inc. 2019 Q3 - Results - Earnings Call Presentation
  • Seeking Alpha - Article.11/14 15:35
  • Athersys, Announces Healios Receives Notification of Orphan Designation for Acute Respiratory Distress Syndrome Clinical Program in Japan
  • Benzinga.11/14 11:05

更多

所属板块

生物技术和医学研究
+0.66%
制药与医学研究
+0.49%

热门股票

名称
价格
涨跌幅

ATHX 简况

Athersys, Inc. is an international biotechnology company that is focused primarily in the field of regenerative medicine. The Company's MultiStem cell therapy, an allogeneic stem cell product, is its lead platform product and is in later-stage clinical development. Its clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the standard of care is limited or inadequate for many patients.
展开

Webull提供Athersys, Inc.的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。